IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali (PQSAFETY)
This study has been completed.
Sponsor:
University of California, San Francisco
Collaborators:
Malaria Research and Training Center, Bamako, Mali
Radboud University
University of Mississippi Medical Center
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT02535767
First received: August 7, 2015
Last updated: February 2, 2017
Last verified: February 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2016 |
| Primary Completion Date: | January 2016 (Final data collection date for primary outcome measure) |